Indian Ezetimibe Exporters: Complete Supplier Ranking with Market Share — 169 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ezetimibe supplier from India?

PIRAMAL PHARMA LIMITED is the largest ezetimibe exporter from India with a 61.3% market share and export value of $315.6M.

Q: How many ezetimibe suppliers are there in India?

There are 169 active ezetimibe exporters in India, collectively shipping $514.5M worth of ezetimibe across 5,033 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ezetimibe suppliers from India?

The top 5 ezetimibe suppliers from India — PIRAMAL PHARMA LIMITED, ALKEM LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, MEDREICH LIMITED — together control 91.1% of total ezetimibe export value from India.

Suresh Sormare

Ezetimibe

India Pharmaceutical Trade Intelligence

$514.5M169 Suppliers85 CountriesHS 30049099

ExportsIndia → UNITED STATES44.9%India → GERMANY41.4%

ImportsMALTA → India$3.0M GERMANY → India$37.8K

#1 Supplier: PIRAMAL PHARMA

Ezetimibe Suppliers from India (2026) — 169 Exporters, $514.5M Market | TransData Nexus | TransData Nexus

Who Exports Ezetimibe from India — 169 Suppliers Behind a $514.5M Market

India's ezetimibe export market is supplied by 169 active exporters who collectively shipped $514.5M across 5,033 shipments. PIRAMAL PHARMA LIMITED leads with a 61.3% market share, followed by ALKEM LABORATORIES LIMITED and INTAS PHARMACEUTICALS LIMITED. The top 5 suppliers together control 91.1% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Ezetimibe Suppliers & Exporters — 169 manufacturers, $514.5M export market, top destinations and formulations — Ezetimibe supplier data — 169 exporters · $514.5M market · 5,033 shipmentsTransData Nexus · Indian Customs Data

Top Ezetimibe Exporters from India — Ranked by Export Value

PIRAMAL PHARMA LIMITED is the leading ezetimibe exporter from India, holding a 61.3% share of the $514.5M market across 5,033 shipments from 169 exporters. The top 5 suppliers — PIRAMAL PHARMA LIMITED, ALKEM LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, MEDREICH LIMITED — collectively control 91.1% of total export value, indicating a highly concentrated market. Individual shares are: PIRAMAL PHARMA LIMITED (61.3%), ALKEM LABORATORIES LIMITED (21.5%), INTAS PHARMACEUTICALS LIMITED (3.3%), MYLAN LABORATORIES LIMITED (2.5%), MEDREICH LIMITED (2.4%).

Top Ezetimibe Exporters from India

Ranked by export value · 169 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Ezetimibe Exporters from India — Ranked by Export Value. 169 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Ezetimibe — Export Intelligence Video

Visual overview of India's ezetimibe supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's ezetimibe pharmaceutical supplier landscape — $514.5M in total trade, 169 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Ezetimibe exporters

Certification and compliance status for top Ezetimibe suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
PIRAMAL PHARMA LIMITED	Approved	Yes	Yes	Multiple	FDA approvals for various medications; WHO-GMP and EU GMP certified.
ALKEM LABORATORIES LIMITED	Approved	Yes	Yes	Multiple	FDA approvals for various medications; WHO-GMP and EU GMP certified.
INTAS PHARMACEUTICALS LIMITED	Approved	Yes	Yes	Multiple	FDA approvals; WHO-GMP and EU GMP certified; received FDA warning letter in Dece
MYLAN LABORATORIES LIMITED	Approved	Yes	Yes	Multiple	FDA approvals for various medications; WHO-GMP and EU GMP certified.
MEDREICH LIMITED	Approved	Yes	Yes	Multiple	FDA approvals for various medications; WHO-GMP and EU GMP certified.
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Approved	Yes	Yes	Multiple	FDA approvals for various medications; WHO-GMP and EU GMP certified.
MICRO LABS LIMITED	Approved	Yes	Yes	Multiple	FDA approvals for various medications; WHO-GMP and EU GMP certified.
ZYDUS LIFESCIENCES LIMITED	Approved	Yes	Yes	Multiple	FDA approvals for various medications; WHO-GMP and EU GMP certified.
HETERO LABS LIMITED	Approved	Yes	Yes	Multiple	FDA approvals for various medications; WHO-GMP and EU GMP certified.
TORRENT PHARMACEUTICALS LTD	Approved	Yes	Yes	Multiple	FDA approvals for various medications; WHO-GMP and EU GMP certified.

TransData Nexus reviewed the regulatory standing of 10 leading Ezetimibe exporters from India. 10 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Ezetimibe sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal center for the production of Active Pharmaceutical Ingredients (APIs). The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. This concentration of API manufacturers makes Hyderabad a critical hub for sourcing raw materials essential for Ezetimibe production.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical formulations industry. Gujarat contributes nearly 28% of India's pharmaceutical production and houses leading companies such as Zydus Lifesciences and Intas Pharmaceuticals. These firms are instrumental in the formulation and export of Ezetimibe, leveraging the region's advanced infrastructure and regulatory compliance to meet global standards.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products. This region is home to the headquarters of major pharmaceutical companies like Sun Pharmaceutical Industries Limited, which plays a significant role in the export of Ezetimibe. The proximity to major ports and well-established logistics networks facilitates efficient distribution to international markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Ezetimibe exporters from India

May 2025

Capacity Expansion

Piramal Pharma Limited — Piramal Pharma invests $90M to expand two US facilities

Piramal Pharma Limited announced a $90 million investment to expand its facilities in Lexington, Kentucky, and Riverview, Michigan. The expansion aims to enhance sterile injectables and antibody-drug conjugate (ADC) capabilities, responding to increased demand in these sectors. - IMPACT: This expansion may bolster Piramal's production capacity, potentially increasing Ezetimibe exports.

Impact: This expansion may bolster Piramal's production capacity, potentially increasing Ezetimibe exports.

June 2025

Capacity Expansion

Piramal Pharma Limited — Piramal Pharma breaks ground on $90M Lexington facility expansion

Piramal Pharma Solutions commenced construction on the Lexington, Kentucky facility expansion, part of the previously announced $90 million investment. The project aims to more than double manufacturing capacity for sterile injectables and ADC therapies by late 2027. - IMPACT: The increased capacity could enhance Piramal's ability to meet global Ezetimibe demand.

Impact: The increased capacity could enhance Piramal's ability to meet global Ezetimibe demand.

Common Questions — Ezetimibe Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which ezetimibe supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, PIRAMAL PHARMA LIMITED leads with 269 recorded shipments worth $315.6M. ALKEM LABORATORIES LIMITED (389 shipments) and INTAS PHARMACEUTICALS LIMITED (333 shipments) are also established high-volume exporters.

Q How many ezetimibe manufacturers are there in India?

India has 169 active ezetimibe exporters with a combined export market of $514.5M across 5,033 shipments to 85 countries. The top 5 suppliers hold 91.1% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for ezetimibe from India?

Average FOB unit price: $20.96 per unit, ranging from $0.01 to $6192.71. Average shipment value: $102.2K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ezetimibe

Ezetimibe

Who Exports Ezetimibe from India — 169 Suppliers Behind a $514.5M Market

Top Ezetimibe Exporters from India — Ranked by Export Value

Top Ezetimibe Exporters from India

Related Analysis

Need Details?

Ezetimibe — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Piramal Pharma Limited — Piramal Pharma invests $90M to expand two US facilities

Piramal Pharma Limited — Piramal Pharma breaks ground on $90M Lexington facility expansion

Common Questions — Ezetimibe Suppliers from India

Q Which ezetimibe supplier from India is the most reliable for bulk orders?

Q How many ezetimibe manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for ezetimibe from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Piramal Pharma Limited — Piramal Pharma acquires additional stake in Yapan Bio

Analysis Methodology